Clinical Trial Update: Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immune profiles in chronic rhinosinusitis patients after mepolizumab treatment; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Rhinosinusitis Without Nasal Polyps
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: St. Paul's Sinus Centre | Conditions: Chronic Rhinosinusitis With Nasal Polyps, Asthma | Phase 4 | Status: RECRUITING